Neuroendocrine tumours in 2012: Insights into signalling pathways could individualize therapy
2013 (English)In: Nature reviews. Endocrinology, ISSN 1759-5029, Vol. 9, no 2, 70-72 p.Article in journal, Editorial material (Refereed) Published
euroendocrine tumours are a heterogeneous group of neoplasms with various clinical presentations, growth rates and responses to available therapies. Studies published in 2012 have provided insights into tumourcell signalling that will increase our knowledge of tumour biology and molecular genetics, making it possible to personalize patient care.
Place, publisher, year, edition, pages
2013. Vol. 9, no 2, 70-72 p.
Cancer and Oncology
IdentifiersURN: urn:nbn:se:uu:diva-192592DOI: 10.1038/nrendo.2012.250ISI: 000314738900003PubMedID: 23296177OAI: oai:DiVA.org:uu-192592DiVA: diva2:600109